Resurgence Alcohol & Drug Rehab Publishes New Clinical Resource Examining Risks of Mixing Lipitor and Alcohol

JURUPA VALLEY, CA - March 05, 2026 - PRESSADVANTAGE - Resurgence Alcohol & Drug Rehab Riverside has published a new ...

Muse Treatment Publishes In-Depth New Resource Examining the Dangers of Fentanyl-Laced Meth and Public Health Implications

LOS ANGELES, CA - March 04, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has published a ...

WhiteSands Treatment Center Publishes New Resource on Most Effective ADHD Medication for Adults and Its Role in Addiction Treatment Planning

TAMPA, FL - March 09, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational resource ...

Grace Point Treatment Center Publishes New Resource on Website Discussing Coral Ridge Isles Rehab and Structured Paths to Addiction Recovery

FORT LAUDERDALE, FL - March 06, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has published a new educational ...

FDA approves leucovorin for rare genetic condition, but not for autism

The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration suggested might be coming during a White House briefing in September, when ...
The Manila Times

GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF

FDA grants Orphan Drug Designation (ODD) for NTZ for ACLF, a severe condition with no approved therapiesNTZ is being advanced ...
Medscape

FDA OKs Leucovorin for Ultra-Rare Genetic Disorder but Not Autism

The FDA approved leucovorin for cerebral folate deficiency linked to FOLR1 mutations but said evidence is insufficient to support approval for autism.

Programs, aid expand as Erie County's drug deaths decrease

An Erie County task force is advancing efforts to combat drug overdoses and deaths as death figures drop nearly 40% in 2025.

Moment of Clarity Publishes In-Depth Resource on Insurance Coverage for TMS Therapy, Expanding Access to Evidence-Based Mental Health Treatment

LONG BEACH, CA - March 06, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new resource on its ...

FDA approves new use of synthetic vitamin B9 — but not for autism symptoms

The FDA announced a new approved use for the drug leucovorin, which Trump has touted as a treatment for autism. But the approval is for cerebral folate deficiency.
MedPage Today on MSN

Amid Opioid Addiction Treatment, Losing Insurance Tied to Mortality Risk

Health insurance loss, changes "may undermine continuity of critical treatment," researche ...